You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

List of Excipients in API butenafine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing butenafine hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Mylan Pharmaceuticals Inc MENTAX butenafine hydrochloride 0378-6151 BENZYL ALCOHOL
Mylan Pharmaceuticals Inc MENTAX butenafine hydrochloride 0378-6151 CETYL ALCOHOL
Mylan Pharmaceuticals Inc MENTAX butenafine hydrochloride 0378-6151 DIETHANOLAMINE
Mylan Pharmaceuticals Inc MENTAX butenafine hydrochloride 0378-6151 GLYCERIN
Mylan Pharmaceuticals Inc MENTAX butenafine hydrochloride 0378-6151 GLYCERYL MONOSTEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing butenafine hydrochloride

Company Ingredient NDC Excipient
Walgreen Company butenafine hydrochloride 0363-2100 BENZYL ALCOHOL
Walgreen Company butenafine hydrochloride 0363-2100 CETETH-23
Walgreen Company butenafine hydrochloride 0363-2100 CETYL ALCOHOL
Walgreen Company butenafine hydrochloride 0363-2100 GLYCERIN
Walgreen Company butenafine hydrochloride 0363-2100 GLYCERYL STEARATE SE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for butenafine hydrochloride

Excipient focus: BENZYL ALCOHOL

Excipient focus: CETETH-23

Excipient focus: CETYL ALCOHOL

Excipient focus: DIETHANOLAMINE

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: GLYCERYL STEARATE SE

Excipient focus: PETROLATUM

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLENE GLYCOL DICAPRYLATE

Excipient focus: SODIUM BENZOATE

Excipient focus: STEARIC ACID

Excipient focus: TROLAMINE

Excipient focus: WATER

Excipient focus: WHITE PETROLATUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group